Ocular PEComas are frequently melanotic and TFE3-translocated: report of two cases including the first description of PRCC-TFE3 fusion in PEComa.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
May 2021
Historique:
received: 26 05 2020
accepted: 07 07 2020
revised: 28 06 2020
pubmed: 18 7 2020
medline: 18 5 2021
entrez: 18 7 2020
Statut: ppublish

Résumé

Ocular perivascular epithelioid cell tumor (PEComa) is exceedingly rare. We reported two examples involving the choroid and subconjunctival tissue, respectively, in patients aged 17 and 20 years. Both tumors comprised packets and sheets of large polygonal cells with moderately pleomorphic nuclei and prominent nucleoli, traversed by delicate fibrovascular septa. Melanin pigmentation was present in one case. The tumors showed HMB45 and TFE3 immunoreactivity. TFE3 gene translocation was confirmed by FISH break-apart probes. RNA seq revealed PRCC-TFE3 and NONO-TFE3 fusions, with the former representing the first description of PRCC-TFE3 in PEComa. Critical reappraisal of the reported cases showed that ocular PEComa frequently affected young patents with melanin pigmentation, frequent TFE3 protein expression, and/or TFE3 gene translocation. No recurrence or metastasis was reported after complete excision despite the presence of cytologic atypia.

Identifiants

pubmed: 32676967
doi: 10.1007/s00428-020-02890-w
pii: 10.1007/s00428-020-02890-w
doi:

Substances chimiques

Basic Helix-Loop-Helix Leucine Zipper Transcription Factors 0
Biomarkers, Tumor 0
Cell Cycle Proteins 0
Melanins 0
Neoplasm Proteins 0
PRCC protein, human 0
TFE3 protein, human 0

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1025-1031

Subventions

Organisme : Fujian Provincial Department of Science and Technology
ID : 2018Y2003 and 2019L3017

Références

Goldblum JR, Folpe AL, Weiss SW (2020) Soft tissue tumors showing melanocytic differentiation. In: Goldblum JR, Folpe AL, Weiss SW (eds) Enzinger and Weiss’s soft tissue tumors, 7th edn. Elsevier, Philadelphia, pp 1009–1051
Argani P, Aulmann S, Illei PB, Netto GJ, Ro J, Cho HY, Dogan S, Ladanyi M, Martignoni G, Goldblum JR, Weiss SW (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34:1395–1406
doi: 10.1097/PAS.0b013e3181f17ac0
Agaram NP, Sung YS, Zhang L, Chen CL, Chen HW, Singer S, Dickson MA, Berger MF, Antonescu CR (2015) Dichotomy of genetic abnormalities in PEComas with therapeutic implications. Am J Surg Pathol 39:813–825
doi: 10.1097/PAS.0000000000000389
Iyengar P, Deangelis DD, Greenberg M, Taylor G (2005) Perivascular epithelioid cell tumor of the orbit: a case report and review of the literature. Pediatr Dev Pathol 8:98–104
doi: 10.1007/s10024-004-5055-0
Furusato E, Cameron JD, Newsom RW, Fujishiro T, Kojima T, Specht CS, Fetsch JF, Furusato B, Sesterhenn IA, Rushing EJ (2010) Ocular perivascular epithelioid cell tumor: report of 2 cases with distinct clinical presentations. Hum Pathol 41:768–772
doi: 10.1016/j.humpath.2009.12.006
Lu JP, Chen G, Zhu WF (2014) Orbital mass. Zhonghua Bing Li Xue Za Zhi 43:412–413
Goto H, Usui Y, Nagao T (2015) Perivascular epithelioid cell tumor arising from ciliary body treated by local resection. Ocul Oncol Pathol 1:88–92
doi: 10.1159/000369330
Nair AG, Gore SS, Ganvir AY, Adulkar NG, Gopinathan I, Murthy AK, Potdar NA, Shinde CA (2018) Giant perivascular epithelioid cell tumor of the orbit: a clinicopathological analysis and review of the literature. Ocul Oncol Pathol 4:272–279
doi: 10.1159/000484425
Alam MS, Mukherjee B, Krishnakumar S, Biswas J (2017) Malignant perivascular epithelioid cell tumor of the orbit: report of a case and review of literature. Indian J Ophthalmol 65:889–891
doi: 10.4103/ijo.IJO_331_17
Varan A, Bayhan T, Kiratli H, Özoğul E, Kösemehmetoğlu K, Bulut E, Akyüz C (2017) An orbital perivascular epithelioid cell tumor in a 7-year-old boy: case report and review of the literature. J Aapos 21:325–328 e1
doi: 10.1016/j.jaapos.2017.05.022
Paliogiannis P, Palmieri G, Tanda F, Cossu A (2017) Perivascular epithelioid cell tumors (PEComas) of the orbit. J Pathol Transl Med 51:7–8
doi: 10.4132/jptm.2016.10.26
Lubo I, Fermin I, Massarelli O, Gobbi R, Cossu RP (2016) Perivascular epithelioid cell tumour with intraorbital location: report of a case and review of the literature. Case Rep Pathol 2016:1936421
pubmed: 26925281 pmcid: 4746388
Guthoff R, Guthoff T, Mueller-Hermelink HK, Sold-Darseff J, Geissinger E (2008) Perivascular epithelioid cell tumor of the orbit. Arch Ophthalmol 126:1009–1011
doi: 10.1001/archopht.126.7.1009
Folpe AL, Kwiatkowski DJ (2010) Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol 41:1–15
doi: 10.1016/j.humpath.2009.05.011
Argani P, Zhang L, Shung YS et al (2020) A novel RBMX-TFE3 gene fusion in a highly aggressive pediatric renal perivascular epithelioid tumor. Genes Chromosomes Cancer 59:58–63
Argani P, Zhong M, Reuter VE, Fallon JT, Epstein JI, Netto GJ, Antonescu CR (2016) TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol 40:723–737
doi: 10.1097/PAS.0000000000000631
Dickson B, Chung C, Hurlbut D et al (2020) Genetic diversity in alveolar soft part sarcoma: a subset contain variant fusion genes, highlighting broader molecular kinship with other MiT family tumors. Genes Chromosomes Cancer 59:23–29
doi: 10.1002/gcc.22803
Utpatel K, Calvisi DF, Kohler G et al (2020) Complexity of PEComas: a diagnostic approach, molecular background, clinical management. Pathologe 41(suppl 1):9–19
Sharain RF, Gown AM, Greipp PT, Folpe AL (2019) Immunohistochemistry for TFE3 lacks specificity and sensitivity in the diagnosis of TFE3-rearranged neoplasms: a comparative, 2-laboratory study. Hum Pathol 87:65–74
doi: 10.1016/j.humpath.2019.02.008

Auteurs

Y Gao (Y)

Department of Clinical Pathology, Caritas Medical Centre, Sham Shui Po, Hong Kong.

G Chen (G)

Department of Pathology, Fujian Medical University Cancer Hospital and Fujian Cancer Hospital Fuzhou, Fuzhou, China.

C Chow (C)

Department of Cellular and Anatomical Pathology, Chinese University of Hong Kong, Hong Kong, Hong Kong.

I Io (I)

Department of Ophthalmology, Caritas Medical Centre, Sham Shui Po, Hong Kong.

E W N Wong (EWN)

Department of Ophthalmology, Caritas Medical Centre, Sham Shui Po, Hong Kong.

W M S Tsui (WMS)

Department of Pathology, Tseung Kwan O Hospital, Tseung Kwan O, Hong Kong.

W Y Lam (WY)

Department of Clinical Pathology, Caritas Medical Centre, Sham Shui Po, Hong Kong.

K F To (KF)

Department of Cellular and Anatomical Pathology, Chinese University of Hong Kong, Hong Kong, Hong Kong.

J K C Chan (JKC)

Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China.

Wah Cheuk (W)

Department of Pathology, Queen Elizabeth Hospital, Hong Kong, China. cwzz01@ha.org.hk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH